Integrated BioPharma, Inc.

72 articles about Integrated BioPharma, Inc.

• Integrated BioPharma Reports Results for its Quarter Ended December 31, 2023

  2/12/2024

  Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2023.

• Integrated BioPharma Reports Results for its Quarter Ended September 30, 2023

  11/9/2023

  Integrated BioPharma, Inc. reports its financial results for the quarter ended September 30, 2023.

• Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2023

  9/15/2023

  Integrated BioPharma, Inc. reports its financial results for the quarter and fiscal year ended June 30, 2023.

• Integrated BioPharma Reports Results for its Quarter Ended March 31, 2023

  5/11/2023

  Integrated BioPharma, Inc. reports its financial results for the quarter ended March 31, 2023.

• Integrated BioPharma Announces the Sudden Death of Its Executive Chairman and President

  3/21/2023

  Integrated BioPharma, Inc. announced that Edward G. Kay, the Company's Founder, Executive Chairman and President passed away yesterday evening.

• Integrated BioPharma Reports Results for its Quarter Ended December 31, 2022

  2/10/2023

  Integrated BioPharma, Inc. reports its financial results for the quarter ended December 31, 2022.

• Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2022

  9/13/2022

  Integrated BioPharma, Inc. reports its financial results for the quarter and fiscal year ended June 30, 2022.

• Integrated BioPharma Announces Change in Directors

  6/21/2022

  Integrated BioPharma, Inc. announced Mr. Carl DeSantis has resigned as a Class I Director from the Company's Board of Directors and Mr. Damon DeSantis, has been elected to serve as a Class I Director to fill the vacancy left by Mr. Carl DeSantis.

• Integrated BioPharma Reports Results for its Quarter Ended March 31, 2022

  5/12/2022

  Integrated BioPharma, Inc. reports its financial results for the fiscal quarter ended March 31, 2022.

• Integrated BioPharma Reports Results for its Quarter Ended December 31, 2021

  2/10/2022

  Revenue for the quarter ended December 31, 2021 was $14.6 million compared to $14.3 million for the quarter ended December 31, 2020, an increase of $0.3 million or 2.1%.

• Integrated BioPharma Reports Results for its Quarter Ended September 30, 2021

  11/10/2021

  Integrated BioPharma, Inc. reports its financial results for the quarter ended September 30, 2021.

• Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2021

  9/2/2021

  Revenue for the quarter ended June 30, 2021 was $17.1 million compared to $13.5 million for the quarter ended June 30, 2020, an increase of $3.6 million or 26.7%.

• Integrated BioPharma Reports Results for its Quarter Ended March 31, 2021

  5/13/2021

  Revenue for the quarter ended March 31, 2021 was $17.1 million compared to $13.6 million for the quarter ended March 31, 2020, an increase of $3.4 million or 25.2%.

• Integrated BioPharma Announces Launch of Investors Website

  4/8/2021

  Integrated BioPharma Announces Launch of Investors Website

• Integrated BioPharma Reports Results for its Quarter Ended December 31, 2020

  2/12/2021

  Integrated BioPharma, Inc. reports its financial results for the quarter ended December 31, 2020.

• Integrated BioPharma Announces Upgrade to OTCQX

  1/22/2021

  Integrated BioPharma, Inc. (OTCQX:INBP) , upgraded to the OTCQX; Best Market from OTCQB; Venture Market as of today. OTC Markets Group Inc. (OTCQX:OTCM) is an operator of financial markets for 11,000 U.S. and global securities. Integrated BioPharma, Inc. begins trading today on OTCQX

• Integrated BioPharma Reports Results for its Quarter Ended September 30, 2020

  11/12/2020

  Revenue for the quarter ended September 30, 2020 was $15.2 million compared to $11.4 million for the quarter ended September 30, 2019, an increase of $3.8 million or 33.0%.

• Integrated BioPharma Reports Results for its Fiscal Year Ended June 30, 2020

  9/23/2020

  Integrated BioPharma, Inc. (OTCQB:INBP) (the "Company" or "INBP") reports its financial results for the fiscal year ended June 30, 2020.

• Integrated BioPharma, Inc. Announces Voluntary Delisting of Its Common Stock

  4/14/2009

• Integrated BioPharma, Inc. Announces Resignation of Chief Executive Officer Jeffrey R. Leach

  4/8/2009